Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Towa Pharmaceutical Co Ltd
F:6QC
Towa Pharmaceutical Co Ltd
F:6QC
Price:
19.9
EUR
Market Cap:
€979.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Towa Pharmaceutical Co Ltd
F:6QC
|
JP |
|
C
|
China Communications Services Corp Ltd
XHAM:CMW
|
HK |
|
Acerinox SA
MAD:ACX
|
ES |
|
F
|
Future City Leasehold Real Estate Investment Trust
SET:FUTURERT
|
TH |
Wall St Price Targets
6QC Price Forecast
Based on 9 analysts
Based on 9 analysts
+26% Upside
from
€19.9
today
Towa Pharmaceutical Co Ltd (6QC)’s 12-month stock price forecast through October 2027 has a consensus target of €25.05, implying 26% upside. The forecast is based on price targets from 9 Wall Street analysts.
6QC Analyst Rating
No ratings yet
No ratings yet
Towa Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6QC's stock price target?
Price Target
25.05
EUR
25.05
EUR
According to Wall Street analysts, the average 1-year price target for 6QC is 25.05 EUR with a low forecast of 18.77 EUR and a high forecast of 27.42 EUR.
What is the Revenue forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 9%.
What is the Pre-Tax Income forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
39%
39%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 39%.
What is the Net Income forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
68%
68%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 68%.